Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DarioHealth Corp. stock logo
DRIO
DarioHealth
$7.10
-2.3%		$7.12
$5.84
▼
$17.74
$53.38M1.1118,515 shs9,838 shs
electroCore, Inc. stock logo
ECOR
electroCore
$6.09
$7.89
$4.16
▼
$10.49
$54.86M0.9374,149 shs143,880 shs
HIND
Vyome
$2.16
+1.9%		$2.19
$1.75
▼
$18.60
$14.84M1.4812,938 shs11,045 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$1.46
+4.3%		$1.77
$1.26
▼
$8.59
$54.26M1.62198,126 shs86,971 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.00%-6.68%-0.14%+0.03%-33.90%
electroCore, Inc. stock logo
ECOR
electroCore
0.00%-1.62%-30.56%-8.28%-10.04%
HIND
Vyome
0.00%+2.91%-7.83%+8.16%+211,999,900.00%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%0.00%-18.60%-53.33%-80.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DarioHealth Corp. stock logo
DRIO
DarioHealth
$7.10
-2.3%		$7.12
$5.84
▼
$17.74
$53.38M1.1118,515 shs9,838 shs
electroCore, Inc. stock logo
ECOR
electroCore
$6.09
$7.89
$4.16
▼
$10.49
$54.86M0.9374,149 shs143,880 shs
HIND
Vyome
$2.16
+1.9%		$2.19
$1.75
▼
$18.60
$14.84M1.4812,938 shs11,045 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$1.46
+4.3%		$1.77
$1.26
▼
$8.59
$54.26M1.62198,126 shs86,971 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.00%-6.68%-0.14%+0.03%-33.90%
electroCore, Inc. stock logo
ECOR
electroCore
0.00%-1.62%-30.56%-8.28%-10.04%
HIND
Vyome
0.00%+2.91%-7.83%+8.16%+211,999,900.00%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%0.00%-18.60%-53.33%-80.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DarioHealth Corp. stock logo
DRIO
DarioHealth
2.00
Hold$10.5047.89% Upside
electroCore, Inc. stock logo
ECOR
electroCore
2.00
Hold$18.00195.57% Upside
HIND
Vyome
2.40
Hold$15.00594.44% Upside
Nyxoah SA stock logo
NYXH
Nyxoah
2.25
Hold$5.96308.39% Upside

Current Analyst Ratings Breakdown

Latest HIND, NYXH, DRIO, and ECOR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/29/2026
HIND
Vyome
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/10/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/9/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$2.85
6/24/2026
electroCore, Inc. stock logo
ECOR
electroCore
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/17/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$5.00 ➝ $3.00
5/22/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
5/14/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00 ➝ $10.00
5/13/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$9.00 ➝ $7.00
5/13/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$11.00
5/12/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$8.00 ➝ $5.00
5/11/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DarioHealth Corp. stock logo
DRIO
DarioHealth
$22.36M2.33N/AN/A$10.05 per share0.71
electroCore, Inc. stock logo
ECOR
electroCore
$32.03M1.72N/AN/A($0.21) per share-29.00
HIND
Vyome
$320K47.39N/AN/A$0.67 per share3.22
Nyxoah SA stock logo
NYXH
Nyxoah
$11.33M4.99N/AN/A$1.43 per share1.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$41.71M-$8.88N/AN/AN/A-192.23%-60.52%-37.08%8/11/2026 (Estimated)
electroCore, Inc. stock logo
ECOR
electroCore
-$13.97M-$1.77N/AN/AN/A-44.08%-1,956.38%-83.30%8/6/2026 (Estimated)
HIND
Vyome
-$10.26M-$12.27N/AN/AN/AN/A-203.92%-134.16%N/A
Nyxoah SA stock logo
NYXH
Nyxoah
-$101.92M-$2.48N/AN/AN/A-543.21%-163.73%-80.24%8/5/2026 (Estimated)

Latest HIND, NYXH, DRIO, and ECOR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$0.74N/AN/AN/A$5.92 millionN/A
8/6/2026Q2 2026
electroCore, Inc. stock logo
ECOR
electroCore
-$0.41N/AN/AN/A$9.49 millionN/A
8/5/2026Q2 2026
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.47N/AN/AN/A$8.64 millionN/A
5/12/2026Q1 2026
HIND
Vyome
N/A-$0.15N/A-$0.15N/A$0.03 million
5/12/2026Q1 2026
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.54-$0.43+$0.11-$0.43$7.05 million$7.38 million
5/6/2026Q1 2026
electroCore, Inc. stock logo
ECOR
electroCore
-$0.59-$0.59N/A-$0.59$9.01 million$9.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DarioHealth Corp. stock logo
DRIO
DarioHealth
N/AN/AN/AN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
HIND
Vyome
N/AN/AN/AN/AN/A
Nyxoah SA stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.50
3.07
2.62
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.02
0.86
HIND
Vyome
N/A
4.27
4.27
Nyxoah SA stock logo
NYXH
Nyxoah
0.53
0.99
0.88

Institutional Ownership

CompanyInstitutional Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
33.39%
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
HIND
Vyome
22.06%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A

Insider Ownership

CompanyInsider Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
3.50%
electroCore, Inc. stock logo
ECOR
electroCore
7.80%
HIND
Vyome
33.00%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
DarioHealth Corp. stock logo
DRIO
DarioHealth
2007.34 million7.09 millionNo Data
electroCore, Inc. stock logo
ECOR
electroCore
509.02 million8.31 millionNot Optionable
HIND
Vyome
507.02 million4.70 millionN/A
Nyxoah SA stock logo
NYXH
Nyxoah
11038.76 millionN/ANot Optionable

Recent News About These Companies

Health Catalyst (NASDAQ:HCAT) vs. Nyxoah (NASDAQ:NYXH) Head-To-Head Survey
August 2 at 2:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30935596
Nyxoah (NASDAQ:NYXH) Upgraded by Wall Street Zen to "Hold" Rating
August 1 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30933691
Nyxoah (NASDAQ:NYXH) Stock Rating Upgraded by Wall Street Zen
August 1 at 1:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-nasdaqnyxh-stock-rating-upgraded-by-wall-street-zen-2026-08-01/
Nyxoah (NYXH) Projected to Release Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-nyxh-projected-to-release-earnings-on-wednesday-2026-07-29/
Head to Head Survey: Nyxoah (NASDAQ:NYXH) and Zhongchao (NASDAQ:ZCMD)
July 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30927656
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333855/0/en/nyxoah-to-release-second-quarter-2026-financial-results-on-august-5-2026.html
Short Interest in Nyxoah SA (NASDAQ:NYXH) Drops By 63.9%
July 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/short-interest-in-nyxoah-sa-nasdaqnyxh-drops-by-639-2026-07-13/
Nyxoah touts Genio US launch traction, reimbursement stability at investor day
July 11, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/nyxoah-touts-genio-us-launch-traction-reimbursement-stability-at-investor-day/ar-AA27FKRx
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
July 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-touts-genio-us-launch-traction-reimbursement-stability-at-investor-day-2026-07-10/
Nyxoah SA (NYXH) Analyst/Investor Day Transcript
July 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4920699-nyxoah-sa-nyxh-analyst-investor-day-transcript
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution
July 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-091502439.html
Nyxoah reports Q2 2026 preliminary revenue of €7.7M
July 7, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/nyxoah-reports-q2-2026-preliminary-revenue-of-77m/ar-AA27q7EB
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323627/0/en/nyxoah-announces-preliminary-results-for-the-second-quarter-of-2026.html
Information on the total number of voting rights and shares
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3320146/0/en/information-on-the-total-number-of-voting-rights-and-shares.html
Publication relating to transparency notifications
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3319310/0/en/publication-relating-to-transparency-notifications.html
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns
June 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-043059720.html
Nyxoah to Host Investor Day in New York on July 8, 2026
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/23/3316416/0/en/nyxoah-to-host-investor-day-in-new-york-on-july-8-2026.html
Nyxoah (NYXH) Gets a Hold from Stifel Nicolaus
June 23, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2594024/nyxoah-nyxh-gets-a-hold-from-stifel-nicolaus/
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026
June 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/19/3314894/0/fr/invitation-%c3%a0-assister-%c3%a0-l-assembl%c3%a9e-g%c3%a9n%c3%a9rale-extraordinaire-des-actionnaires-de-la-soci%c3%a9t%c3%a9-qui-se-tiendra-le-9-juillet-2026.html
Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026
June 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/19/3314894/0/en/invitation-to-attend-the-extraordinary-shareholders-meeting-of-the-company-to-be-held-on-july-9-2026.html
Publication relating to transparency notifications
June 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/17/3313828/0/en/publication-relating-to-transparency-notifications.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcoa logo displayed in an aluminum manufacturing facility with coiled sheets and stacked metal ingots.
Alcoa's $4.1 Billion South32 Deal: Opportunity Behind the 9% Drop
By Jeffrey Neal Johnson | July 6, 2026
Robotics components including a sensor module, circuit board, motors, and a mechanical joint arranged on a table.
3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout
By Ryan Hasson | July 17, 2026
Exterior view of a large data center building with electrical transformers, piping, and utility equipment in the foreground.
AI’s Power Crunch Fuels a Pivot for These 2 Oilfield Stocks
By Jeffrey Neal Johnson | July 16, 2026
Illustration of a desk with miniature buildings, a monitor showing a portfolio dashboard, and fund brochures for growth, value, and industrial ETFs.
3 Value ETFs to Consider as Growth Stocks Lag Behind
By Nathan Reiff | July 28, 2026
Illustration of a computer chip on a circuit board connected to a glowing network of nodes representing AI technology.
These 3 AI Winners Don’t Sell the Tech—They Use It
By Nathan Reiff | July 27, 2026
DarioHealth stock logo

DarioHealth NASDAQ:DRIO

$7.10 -0.17 (-2.34%)
Closing price 04:00 PM Eastern
Extended Trading
$7.08 -0.01 (-0.21%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

electroCore stock logo

electroCore NASDAQ:ECOR

$6.09 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$6.15 +0.06 (+0.99%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Vyome NASDAQ:HIND

$2.16 +0.04 (+1.89%)
Closing price 03:59 PM Eastern
Extended Trading
$2.07 -0.09 (-4.35%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$1.46 +0.06 (+4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$1.46 0.00 (-0.34%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas